[Possible serotoninergic syndrome associated with coadministration of paroxetine and tramadol].
Llinares-Tello
Francisca
F
Escrivá-Moscardó
Salvador
S
Martínez-Pastor
Francisco
F
Martínez-Mascaraque
Pedro
P
D000368:Aged; D000369:Aged, 80 and over; D000465:Algorithms; D000701:Analgesics, Opioid / Q000008:administration & dosage*; D018687:Antidepressive Agents, Second-Generation / Q000008:administration & dosage* / Q000009:adverse effects; D003866:Depressive Disorder / Q000188:drug therapy; D004347:Drug Interactions; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D007049:Iatrogenic Disease; D010003:Osteoarthritis / Q000188:drug therapy; D017374:Paroxetine / Q000008:administration & dosage* / Q000009:adverse effects; D020230:Serotonin Syndrome / Q000139:chemically induced / Q000175:diagnosis*; D017367:Selective Serotonin Reuptake Inhibitors / Q000008:administration & dosage* / Q000009:adverse effects*; D013997:Time Factors; D014147:Tramadol / Q000008:administration & dosage*
D000701:Analgesics, Opioid; D018687:Antidepressive Agents, Second-Generation; D017374:Paroxetine; D017367:Selective Serotonin Reuptake Inhibitors; D014147:Tramadol